Quiz
2
Order
3
Lab
4
Results
5
Report
6
Plan

Thyroid

Tumour Marker for Medullary Thyroid Cancer (Calcitonin)

Thyroid

Tumour Marker for Medullary Thyroid Cancer (Calcitonin)

S-Calcitonin measures the level of calcitonin, a hormone produced by the C cells of the thyroid gland, used primarily in the evaluation of medullary thyroid carcinoma.

1 295 SEK

VAT-exempt medical service

  • Results in 5 working days
  • 116 sampling locations
  • No doctor's referral needed
  • Sample: Blood (venous)
  • Laboratory: Synlab
Find a sampling location →

What does this test measure?

Calcitonin is a peptide hormone produced by the parafollicular C cells of the thyroid gland. It plays a role in calcium and bone metabolism by opposing the action of parathyroid hormone. Clinically, the calcitonin blood test is most commonly used as a tumour marker for medullary thyroid carcinoma (MTC), a rare type of thyroid cancer originating in the C cells. It may also be ordered when evaluating thyroid nodules or monitoring patients after thyroid cancer treatment.

Calcitonin testing is indicated when medullary thyroid carcinoma is suspected, when thyroid nodules require further evaluation, or for ongoing surveillance in patients with a personal or family history of MTC or multiple endocrine neoplasia (MEN) syndromes. It is also used postoperatively to monitor for recurrence after thyroid cancer surgery.

What a high value can mean

Elevated calcitonin levels may indicate medullary thyroid carcinoma, C-cell hyperplasia, or other conditions that stimulate C-cell activity. The degree of elevation often correlates with tumour size and burden. Mildly elevated levels can sometimes be caused by other factors, including chronic kidney disease, other cancers, and certain medications. A significantly raised calcitonin warrants further investigation, including imaging and potential biopsy.

What a low value can mean

Low or undetectable calcitonin levels are considered normal and indicate that C-cell activity is within the expected range. After successful treatment for medullary thyroid carcinoma, low calcitonin is a favourable indicator suggesting no residual disease.

Read more about this marker →

Associated symptoms

  • Thyroid nodule detected on examination or imaging
  • Persistent hoarseness or voice changes
  • Difficulty swallowing
  • Lump or swelling in the neck
  • Unexplained diarrhoea (in advanced MTC)
  • Facial flushing (in advanced MTC)

Who should consider this test

  • Individuals with thyroid nodules requiring further workup
  • People with suspected or confirmed medullary thyroid carcinoma
  • Those with a family history of MTC or MEN syndromes
  • Patients post-thyroidectomy for MTC, to monitor for recurrence
  • Individuals with RET gene mutations

Before your appointment

No special preparation is needed. Bring valid identification to your appointment.

  • Bring photo ID to the sampling location.
  • You do not need a doctor's referral — your referral is issued when you order.
  • Tell the staff which test you have ordered if they ask.

How it works

  1. 1

    Order your test

    Choose your test and pay online. Your lab referral is created straight away.

  2. 2

    Give your sample

    Visit any of our partner sampling locations. No appointment needed at most of them.

  3. 3

    The lab analyses it

    Your sample is analysed at an accredited Swedish laboratory.

  4. 4

    Get your results

    Your values appear in your account with reference ranges and an explanation of each marker.

Good to know

Is calcitonin only related to thyroid cancer?

While calcitonin is best known as a marker for medullary thyroid carcinoma, mildly elevated levels can occur with C-cell hyperplasia, chronic kidney disease, and certain other conditions. The clinical significance depends on the degree of elevation and the patient's overall clinical picture.

How is calcitonin different from other thyroid tests?

Most thyroid tests (TSH, T4, T3) evaluate thyroid hormone production and metabolism. Calcitonin is not a thyroid hormone test; it specifically assesses C-cell activity in the thyroid and is used primarily in cancer screening and monitoring.

Can calcitonin levels be used to monitor treatment?

Yes. After surgery for medullary thyroid carcinoma, calcitonin levels are monitored regularly. A decline to undetectable levels suggests successful treatment, while rising levels may indicate recurrence or residual disease.